Table 4. Tumor types of 171 cancer cases with hierarchal association of HIV infection/AIDS.
| HIV Serology | ||||
| Primary Tumor Type | Clinical CriteriaOnly (n = 124) | Initial HIV(+) Serology (n = 25) | Subsequent ConfirmedHIV(+) Serology (n = 22) | Total (n = 171) |
| Kaposi’s Sarcoma (KS) | 37 | 6 | 12 | 55 (32%) |
| Cervix | 31 | 5 | 6 | 42 (25%) |
| Non-Hodgkin’s lymphoma (NHL) | 12 | 3 | 0 | 15 (9%) |
| Head and Neck | 8 | 2 | 0 | 10 (6%) |
| Orbit/Conjunctiva | 7/2 | 0 | 1/0 | 10 (6%) |
| Breast | 5 | 4 | 0 | 9 (5%) |
| Stomach | 3 | 1 | 0 | 4 (2%) |
| Hodgkin’s Disease (HD) | 1 | 3 | 0 | 4 (2%) |
| NOS abdomen/carcinoma in situ NOS | 3/1 | 0 | 0 | 4 (2%) |
| Skin (NOS)/Melanoma | 2/0 | 0 | 0/1 | 3 (2%) |
| Uterus/Vulva | 1/2 | 0 | 0 | 3 (2%) |
| Esophagus | 2 | 0 | 0 | 2 (1%) |
| Colon | 2 | 0 | 0 | 2 (1%) |
| Liver | 1 | 0 | 1 | 2 (1%) |
| Kidney/Prostate | 0/1 | 0 | 1/0 | 2 (1%) |
| Brain | 0 | 1 | 0 | 1 (<1%) |
| Leukemia (NOS) | 1 | 0 | 0 | 1 (<1%) |
| Lung | 1 | 0 | 0 | 1 (<1%) |
| Pancreas | 1 | 0 | 0 | 1 (<1%) |
Of these total cases, 118 (69%) had demonstrable HIV association (i.e., KS, cervix, NHL, conjunctiva and Hodgkin’s disease) and the remaining 53 would be considered non-AIDS-defining cancer. [Notes: Bold italics – known HIV-associated malignancy; NOS – not otherwise specified].